All Updates

All Updates

icon
Filter
Funding
causaLens raises USD 45 million in Series A funding
No-code Software
Jan 28, 2022
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Partnerships
Funding
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
No-code Software

No-code Software

Jan 28, 2022

causaLens raises USD 45 million in Series A funding

Funding

  • causaLens, a no-code platform to build decision making AI systems, raised USD 45 million in Series A funding led by Dorilton Ventures and Molten Ventures, with participation from Generation Ventures, IQ Capital, and GP Bullhound among others. This round values the company at USD 250 million and brings its total funding to USD 51 million.

  • The funds will be used to double the company’s employee base within the year.

  • causaLens is a British company that offers a no-code platform that leverages causal inference technology to introduce nuance and cause-and-effect reasoning into AI-based systems. The platform offers three main tools; 1) a datalake solution that can uncover relevant data based on a given use case (causaLake) 2) a no-code solution to build and deploy Causal AI models (causaLabs), and 3) a tool that provides actionable insights based on the AI models built by users (decisionsOS). The company’s “Causal AI” technology is able to learn cause-and-effect relationships, simulate interventions, and offer computer imagination that isn’t solely dependent on historical data. 

<ul><li> Analyst QuickTake: The no-code AI model building and data science space has seen a large amount of funding within the last two months with companies such as Sigma Computing ( raising USD 300 million ), Pixis ( raising USD 100 million ) and most recently, Vanti Analytics ( raising USD 16 million ). Although it competes with a large number of highly funded companies in this space, causaLens differentiates itself with its offering of “Causal AI”, which enables users to add more nuance, context, and cause-and-effect reasoning to their AI models, which it claims cannot be achieved with regular predictive models that are solely based on historical data.</ul>

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.